KDR and central nervous system cancer: Our data showed that neutralization of PDGF by using either anti-PDGF-AA or anti-PDGF-BB antibody restored VEGFR-2 expression (Fig. 3a) and inhibited FSP-1 expression (Fig. 3b) in glioma-CM-treated ECs.